Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 7/20 | 0.46 |
| ▸ | ITGA2B | P08514 | 7/20 | 0.46 |
| ▸ | F10 | P00742 | 13/20 | 0.45 |
| ▸ | PRSS1 | P07477 | 6/20 | 0.40 |
| ▸ | PRSS2 | P07478 | 6/20 | 0.40 |
| ▸ | PRSS3 | P35030 | 6/20 | 0.40 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.40 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7306771 | 0.93 | ITGB3 (0.50) | ITGB3ITGA2BF10PRSS1PRSS2 | |
| SCHEMBL6600105 | 0.92 | ITGB3 (0.51) | ITGB3ITGA2BF10PRSS1PRSS2 | |
| SCHEMBL7308012 | 0.89 | ITGB3 (0.48) | ITGB3ITGA2BF10PRSS1PRSS2 | |
| SCHEMBL7313241 | 0.88 | ITGB3 (0.46) | ITGB3ITGA2BF10PRSS1PRSS2 | |
| SCHEMBL7314890 | 0.88 | ITGB3 (0.53) | ITGB3ITGA2BF10PRSS1PRSS2 | |
| SCHEMBL6602530 | 0.87 | ITGB3 (0.60) | ITGB3ITGA2BF10PRSS1PRSS2 | |
| SCHEMBL7308688 | 0.87 | ITGB3 (0.46) | ITGB3ITGA2BF10PRSS1PRSS2 | |
| SCHEMBL7307284 | 0.86 | ITGB3 (0.46) | ITGB3ITGA2BF10PRSS1PRSS2 | |
| SCHEMBL7304339 | 0.86 | ITGB3 (0.47) | ITGB3ITGA2BF10PRSS1PRSS2 | |
| SCHEMBL7310120 | 0.86 | ITGB3 (0.47) | ITGB3ITGA2BF10PRSS1PRSS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0741133-A2 | Adhesion receptor antagonists | MERCK PATENT GmbH (DE) | 1996-11-06 | — | — | EP | disclosed |